Search Results for: Sole
these terms, do not use this site. this site may contain other proprietary notices and copyright information that must be observed and followed. information on this site may contain technical inaccuracies or typographical errors. please read this agreement carefully and be aware that makiane, in its sole
such submissions shall be at your own risk. you may not upload to, or distribute or otherwise publish through the site, any content that is any of the following: is libelous, defamatory, obscene, pornographic, abusive, harassing or threatening, or otherwise objectionable to makiane in the company's sole...
https://www.makiane.com/terms-of-use/
conference from "face-to-face" (in-person) to entirely virtual dia's global labeling conference will continue on its current dates april - , in an entirely virtual meeting format, with both speakers and attendees participating remotely via a digital platform. read faq now overview as a direct and sole
rph • executive director, regulatory labeling and promotion intercept pharmaceuticals, inc., united states deborah bebbington • vice president, head labeling bayer plc, united kingdom theresa brunone, ma, ms • compliance director, global labeling glaxosmithkline, united states barbara lachmann, md • sole...
https://www.diaglobal.org/en/conference-listing/meetings/2020/04/global-labeling-conference
societatea nationala nuclearelectrica s.a. polona street, district , , bucharest, romania; tel , fax ; trade registry number: j / / , sole registration code: , paid and subscribed capital: lei , current report in compliance with art. paragraph ( ), letter g) of asf regulation no. / regarding issuers
financial instruments and market operations and with the law no. / regarding issuers of financial instruments and market operations reporting date: . name of the issuing entity: societatea nationala nuclearelectrica s.a. registered office: strada polona nr. , sector , bucuresti phone/fax number: - . / – . sole...
http://www.bvb.ro/infocont/infocont20/SNN_20200723182653_SNN-23072020---CFO-EN.pdf